Amarox Indonesia

PT Amarox Pharma Global, operating as Amarox, is a prominent pharmaceutical company in Indonesia and a subsidiary of the Indian multinational Hetero. The company specializes in the manufacturing, marketing, and distribution of high-quality generic medicines across various therapeutic areas, including oncology, infectious diseases, and gastroenterology. Amarox gained significant recognition for its role in providing critical treatments during the COVID-19 pandemic, such as Remdesivir and Molnupiravir. With a state-of-the-art manufacturing facility in Cikarang, the company aims to improve healthcare accessibility in Indonesia through affordable and effective therapeutic solutions. Amarox continues to expand its portfolio to include biosimilars and complex generics to meet the growing healthcare needs of the Southeast Asian market.